Hillevax company information, Employees & Contact Information

Xoma goes shopping for struggling biotechs, picking up HilleVax and Lava Fierce Biotech

Latham Advises HilleVax Acquisition XOMA Royalty US1 95 Cash Per Share Plus Contingent Value Right Latham & Watkins LLP

Xoma strikes deals to buy struggling biotechs HilleVax, Lava BioPharma Dive

XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. Yahoo Finance

XOMA Royalty Expands Biotech Portfolio: Acquires HilleVax in Cash Plus CVR Deal Worth Over $1.95 Per Share Stock Titan

XOMA Royalty Corporation Completes Tender Offer for HilleVax, Inc. Shares and Merger Finalized Quiver Quantitative

I'm Staying Neutral On XOMA Royalty After The LAVA And HilleVax Deals Seeking Alpha

HilleVax Announces Merger Agreement with XOMA TipRanks

HilleVax (HLVX) Upgraded to Strong Buy: What Does It Mean for the Stock? Yahoo Finance

77.5% Shareholders Accept: XOMA Royalty Acquires Biotech HilleVax in Cash-Plus-CVR Deal Worth $1.95/Share Stock Titan

HilleVax slashes workforce by 40% after norovirus vaccine trial failure Pharmaceutical Technology

HilleVax’s Norovirus Phase 2b Vaccine Trial For Infants Falls Short Contagion Live

Struggling HilleVax, LAVA find saviour in XOMA Royalty FirstWord Pharma

HilleVax’s norovirus phase 2b vaccine trial for infants falls short Contemporary Pediatrics

XOMA Royalty completes acquisition of HilleVax and initiates Nasdaq delisting Investing.com

HilleVax Appoints Sean McLoughlin as Chief Operating Officer citybiz

HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders Business Wire

HilleVax’s norovirus vaccine ineffective in large trial of infants BioPharma Dive

Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants Fierce Biotech

A No-Go for HilleVax as Norovirus Vaccine Fails Mid-Stage Test in Infants MedCity News

East Bay’s Xoma adds two more biotechs to its portfolio - San Francisco Business Times The Business Journals

Hillevax CEO Robert Hershberg sells $48,661 in stock Investing.com

Hillevax stock rises after XOMA Royalty announces acquisition Investing.com

HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer Stock Titan

Here's Why We're Watching HilleVax's (NASDAQ:HLVX) Cash Burn Situation simplywall.st

HilleVax sinks as norovirus jab fails The Pharma Letter

HilleVax Acquired by XOMA, Delisting from Nasdaq TipRanks

Xoma Completes Acquisition of HilleVax TipRanks

XOMA Royalty to acquire HilleVax and LAVA Therapeutics in separate deals Investing.com

Boston biotech’s shares drop nearly 90% on norovirus vaccine data The Business Journals

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate Business Wire

UniQure, Arbutus and HilleVax all lay off staff as biotechs streamline operations and cut costs Fierce Biotech

Takeda's norovirus vaccine spinout, HilleVax, secures $135M crossover Fierce Biotech

How HilleVax Inc. stock valuations compare to rivals - 2025 Technical Patterns & Real-Time Volume Analysis Trung tâm Dự báo KTTV quốc gia

Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session Benzinga

Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire

CEO Moves: How interest rate cuts could boost HilleVax Inc. stock - Market Volume Report & Verified Chart Pattern Trade Signals Trung tâm Dự báo KTTV quốc gia

HilleVax Rakes in $135 Million to Rapidly Progress Norovirus Vaccine BioSpace

Takeda Spins Out HilleVax to Propel Final Development of Norovirus Vaccine BioSpace

Takeda and Frazier Healthcare Partners announce a collaboration to launch HilleVax, Inc. to develop Clinical Stage Norovirus Vaccine Candidate Healthcare Radius